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BACKGROUND: Group B Streptococcus (GBS) is recognized as an 
important cause of maternal and neonatal morbidity and mortality. 
Maternal vaginal carriage of GBS (Streptococcus agalactiae) can 
lead to vertical transmission to the neonate at the time of delivery. 
However, little is known about its prevalence, predictors and 
antibiotic susceptibility pattern in Jimma, Ethiopia. This study 
assessed the prevalence, antimicrobial susceptibility pattern and 
determinants of GBS recto-vaginal colonization among near-term 
pregnant women. 
METHODS: A cross-sectional study was conducted from May to 
August 2015 at Jimma University Medical Centre in Southwest 
Ethiopia. Data through questionnaire and GBS isolates from 
vaginal and rectal swabs were collected. Antimicrobial susceptibility 
testing was performed.  
RESULTS: The overall prevalence of GBS colonization among near 
term pregnant women (35-37 weeks) was 16.3% (22/135). The 
majority of GBS isolates were sensitive to Ampicillin and Penicillin 
G with 95.5% and 90.1%, respectively. Erythromycin and 
clindamycin were resisted by 50% and 40.9% of the isolates, 
respectively, whereas gentamicin was resisted by all isolates. GBS 
colonization was significantly associated with a history of preterm 
delivery (PTD) (AOR: 6.3, 95% CI: 1.42, 28.3) and history of urinary 
tract infection (UTI) during current pregnancy (AOR: 6.4, 95% CI, 
1.95, 21.1). 
CONCLUSION: Our study indicated that one among six near-term 
pregnant women had recto-vaginal GBS colonization. In places 
where universal screening is not feasible, selective screening for 
factors particularly history of PTD and UTI during current 
pregnancy may be a reasonable option. Antibiotic susceptibility 
testing should be performed while using Erythromycin, Clindamycin 
or Gentamicin. 
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Group B streptococcus (GBS) is a member of 
gram-positive streptococci. GBS, also known as 
Streptococcus agalactiae, is found in 15 to 40% 
of healthy women’s colon and vagina (1-3). 
Maternal colonization of GBS is associated with 
an increased risk of urinary tract infection (UTI), 
endometritis, chorioamnionitis, sepsis and 
meningitis (3-8). Moreover, pregnant mothers 
may develop a premature rupture of membranes, 
stillbirth and low birth weight babies (9,10). 
Obvious GBS diseases in the first week of 
delivery are referred to as Early-Onset Disease 
(EOD), whereas Late-Onset Diseases (LOD) 
associated with GBS happens between one week 
to three months after delivery (1-3). 
The prevalence of vaginal colonization 
by GBS among pregnant women varies across the 
world, it has been estimated at 9.1% to 26.7% in 
Iran (11), and 8% - 15% in Europe (12). The 
prevalence of GBS in parts of Africa such as in 
Egypt, Malawi, Nigeria, and Tanzania ranges 
from 11.3% to 23% (13-16). Prevalence of GBS 
recto-vaginal colonization among pregnant 
women has also been studied at different parts of 
Ethiopia including from Addis Ababa, Gondar, 
Adigrat, Mekele, Hawasa, and Jimma that ranges 
from 7.2% to 20.9% (17-22).  
Universal screening of pregnant women 
at 35–37 weeks of gestation for GBS by recto-
vaginal culture is recommended so that 
appropriate intrapartum antibiotic prophylaxis 
(IAP) can be administered for positive cases (1). 
In the United States, since the early 1990s, 
medical interventions have resulted in an 80% 
decline in the incidence of early-onset neonatal 
sepsis due to GBS from 1.7 to less than 0.4 cases 
per 1000 live births in recent years (7). There are 
concerns about the emergence of drug resistance 
in parts of the world where IAP is practiced (1,23-
26). In this study’s location, updated information 
on the trends of drug resistance on commonly 
used drugs is needed for practicing professionals.  
Socio-demographic characteristics like 
greater age, increased parity, low socio-economic 
status, obesity level, place of residence (urban vs. 
rural) have been associated with increased risk of 
maternal colonization of GBS (9,27). In Ethiopia, 
like other resource-limited areas, there are scanty 
studies conducted to assess the prevalence of 
recto-vaginal GBS colonization. Furthermore, 
screening of pregnant women for GBS is not at 
all routine practice. Therefore, this study assessed 
the prevalence of rectovaginal colonization, 
antibiotic susceptibility patterns and determinants 
of GBS isolated from near term pregnant women 
at Jimma University Medical Center (JUMC). 
 
MATERIALS AND METHODS 
 
Study setting: The study was conducted at 
JUMC located in the town of Jimma, 355 km 
Southwest of Addis Ababa. JUMC is the only 
teaching and referral hospital in the southwestern 
part of Ethiopia with a catchment of 15 million 
people. The center has bed occupancy of 650, of 
which 52 beds belong to the obstetric ward. The 
hospital gives 24-hour service of attending 
normal and abnormal labor and basic and 
specialized antenatal care (ANC) follow-ups. 
A cross-sectional study was conducted 
from May 1st to August 31st, 2015.   
The study population consisted of near-
term pregnant women with gestational ages of 35 
to 37 weeks, who attended ANC clinic at JUMC 
during the study period.  
 
Sample size: A sample size was determined 
using a single proportion formula with a 95% 
confidence level (Z of 1.96), and a standard error 
of 0.05. The minimum sample size (n) was 
calculated by taking the carriage rate of S. 
agalactiae (GBS) in pregnant women with a 9% 
carriage rate from a previous study done in 
northern Ethiopia (18). Ten percent of the total 
calculated sample size (n=126) was added for the 
non-response rate, which made the sample size 
139. Among the 139 pregnant women, four 
refused to participate in the study. Thus, a total of 
one hundred thirty-five (135) pregnant women 
were included in the analysis yielding a 97% 
response rate. 
 
Data collection: Data were collected from near-
term pregnant women through a non-probability 
consecutive sampling technique using a checklist 
within the study period by two trained midwives. 
Demographic characteristics and clinical 
outcomes of interest were collected using a well-
structured questionnaire through interview 
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technique using tools from previous studies 
(6,7&17-20).  
For laboratory work, specimens from the 
lower third of the vagina and rectum were 
collected using sterile cotton-tipped swabs in 
separate sterile tubes of Ames transport medium 
by a trained midwife and a gynecologist. It was 
immediately transported to the microbiology 
laboratory of JUMC within one hour of 
collection. The specimens were inoculated 
directly into 5% sheep blood agar (Oxoid 
Limited, Hampshire, UK) plates supplemented 
with 8 µg/ml gentamicin and 15 µg/ml nalidixic 
acid (Biomerieux, France) to prevent the growth 
of contaminants. The plates were incubated at 
37°C aerobically for 24 hours. Cultures were 
examined for beta-hemolytic streptococci colony, 
and all negative plates were re-incubated for an 
additional 24 hours. Suspicious GBS colonies 
were identified by colony morphology, gram 
stain and biochemical tests including catalase, 
sodium hippurate hydrolysis, and Christie, 
Atkins, Munch-Petersen (CAMP) factor 
positivity (4,28). Antimicrobial susceptibility of 
all GBS isolates was determined for commonly 
used antibiotics including Penicillin G (10µg), 
Ampicillin (10µg), Erythromycin (15µg), 
Clindamycin (2µg) and Gentamicin (30µg) by 
using Kirby–Bauer disk diffusion method on 
Mueller–Hinton agar supplemented with 5% 
defibrinated sheep blood. The susceptibility 
results were interpreted according to the 
recommendations of the Clinical and Laboratory 
Standards Institute (CLSI) guidelines for beta 
hemolytic streptococci in 2012(29).  
Women who were found colonized by 
GBS were notified by phone and told to visit the 
ANC clinic. Memos were produced to the 
attending physician indicating that intrapartum 
antibiotics should be given at the onset of true 
labor. 
Statistical analysis: Collected data were used to 
determine associations of selected variables like 
socio-demographic characteristics and obstetric 
and medical histories with positive recto-vaginal 
GBS colonization using SPSS for windows 
version 21.0. Bivariate analysis was carried out 
for identified categorical variables and a p-value 
of ≤ 0.25 was used as a cut-off point to select 
candidate variables for the final multiple logistic 
regression model. Independent predictors 
including history of contraception, early-onset 
neonatal sepsis, premature rupture of membranes, 
preterm delivery, UTI and other variables were 
determined using adjusted odds ratio with 95% 
confidence interval in multiple regression 
analysis at p-value < 0.05.  
 
RESULTS   
Socio-demographic characteristics: The age of 
the study participants ranged from 16 to 38 years 
with a mean of 24.9 (± 4.5) years. The majority 
(62.2%) of the study participants were urban 
residents, married (95%) and Muslim (68%) by 
religion. Thirty-one (23%) of them had 
educational level of beyond secondary school 
(Table 1). 
 
Obstetric characteristics: More than half of the 
women (55.6%) were multigravida and 40.7% of 
them were in the 37th week of their pregnancy. 
Fifteen (11.1%) of the participants had a history 
of preterm birth, 5.2% had premature rupture of 
membranes (PROM), and only 3% had neonates 
with previous early-onset neonatal sepsis 
(EONS). Contraception use among the study 
subjects was 65.2% (Table 2). 
 
Medical characteristics: In our study, 21% of 
the study participants had history of UTI during 
the current pregnancy. Only three participants 
had a history of sexually transmitted infections 
(STI). Testing for human immunodeficiency 
virus (HIV) was done for all participants, and four 
women were found to be seropositive. Eight 
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Table 1: Socio-demographic characteristics of near-term pregnant women involved in the study at JUMC, 
Jimma, Ethiopia from May to August, 2015 (n=135). 
Sociodemographic factor Frequency Percentage 
Age group   
Mean age  24.9 (± 4.5) years  
15-19 years 8 5.9% 
20-24 years 57 42.2% 
25-29 years 47 34.8% 
30-34 years 16 11.9% 
≥35 years 7 5.2% 
Residential location   
Urban 84 62.2% 
Rural 51 37.8% 
Religion    
Muslim   91 67.5% 
Orthodox 31 22.9% 
Protestants 13 9.6% 
Educational status   
No formal education 28 20.7% 
Primary / Secondary 76 56.3% 
Post-secondary  31 23% 
Monthly income    
Mean income  2050.6(± 1145.6) Birr  
<1800 Birr 39 28.8% 
1800-2400 Birr 52 38.5% 
>2400 Birr 44 32.6% 
Marital status   
Married  128 94.8% 
Single 7 5.2% 
 
Table 2: Obstetric and medical characteristics of near-term pregnant women involved in the study at 
JUMC, Jimma, Ethiopia from May to August, 2015 (n=135). 
Obstetric variables Frequency  Percentage  
Gravidity    
1 60 44.4% 
2-4  63 46.7% 
≥5 12 8.9% 
Gestational age    
35 weeks 51    37.8% 
36 weeks 29 21.5% 
37 weeks  55 40.7% 
Previous ANC visit 131 97% 
History of PTD 13 17.3% 
History of PROM 7 5.2% 
History of new-born with EONS 4 3% 
Contraception use  88 65.2% 
UTI during current pregnancy  28 21% 
STI during current pregnancy  3 2% 
HIV infection  4 3% 
Hypertension  8 6% 
JUMC: Jimma University Medical Center; ANC: Antenatal care; PTD: Preterm delivery; PROM: Premature 
rupture of membranes; EONS: Early onset neonatal sepsis; UTI: Urinary tract infection; STI: sexually transmitted 
infections; HIV: Human immune deficiency virus  
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Prevalence of Group B Streptococci: The 
prevalence of GBS colonization among the study 
subjects was 16.3% (22/135). Of all the GBS 
isolates identified, nearly half [45%  
 
 
(10/22)] of them were recovered from the rectum 
only. In 9/22(41%) of the study subjects, GBS 





Figure 1: Site of recovery of GBS colonization among pregnant women attending ANC JUMC, 
Jimma, Ethiopia from May to August, 2015 (n=22) 
 
Antimicrobial susceptibility testing: Twenty-
one (95.5%) and 20 (90.9%) of the 22 GBS 
isolates were susceptible to Ampicillin and 
Penicillin G, respectively. Only two isolates (9%) 
were found to be susceptible to Clindamycin. 
Furthermore, intermediate susceptibility was also 
detected against Erythromycin in one isolate 
(4.5%), and Clindamycin in three isolates 
(13.6%). However, eleven (50%) and nine 
(40.9%) isolates were resistant to Erythromycin 
and Clindamycin, respectively. All of the isolates 




Table 3: Antimicrobial susceptibility pattern of GBS isolated from near term pregnant women at JUMC, 
Jimma, Ethiopia from May to August, 2015 (n=135). 
 
Antibiotics  Disc potency(µg) Susceptible  Intermediate  Resistance  
Ampicillin  10 21(95.5%) - 1(4.5%) 
Penicillin G 10 U 20(90.9%) - 2(9.1%) 
Erythromycin  15 10(45.5%) 3(13.6%)  11(50%) 
Clindamycin  2 10(45.5%) 1(4.5%) 9(40.9%) 
Gentamicin 30 - - 22(100%) 
  
GBS Colonization or its absence among near 
term pregnant women: In univariate analysis, 
completing primary or secondary education, 
history of preterm delivery (PTD) and history of 
UTI during current pregnancy were significantly 
associated with recto-vaginal GBS colonization, 
while the other socio-demographic, obstetric and 
medical characteristics were not significantly 
associated with recto-vaginal GBS colonization 
(Table 4).   
Predictors of recto-vaginal GBS colonization: 
Results from the multiple logistic regression 
analysis are presented in Table 4. Adjusting for 
socio-demographics, obstetric and medical 
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characteristics, history of PTD and UTI during 
current pregnancy were significantly associated 
with GBS colonization. Women with previous 
preterm delivery were 6.3 times more likely to be 
colonized compared to those women with no 
history (AOR: 6.3, 95% CI: 1.42, 28.3). Women 
with history of UTI during current pregnancy 
were 6.4 times more likely to be colonized by 
GBS (AOR: 6.4, 95% CI: 1.95, 21.1) compared 
to women with no such history. Completing 
primary or secondary school and being employee 
were not associated with GBS. 
 
Table 4: Determinants of GBS colonization among near term pregnant women at JUMC, Jimma, Ethiopia 
from May to August, 2015 (n=135). 
 
Variables  GBS         COR:95%,CI         AOR:95%,CI 
 
  Positive 
(N=22) 
Negative 
(N=113)   
Age group     
≤24 years     13(20%) 52(80%) 1.14(0.34 -3.85) 2.5(0.23-27.3) 
25-29 years 5(10.6%) 42(89.4%) 0.54(0.13 - 2.18) 0.15(0.01-2.65) 
≥30 years 4(17.4%) 19(82.6%) 1* 1* 
Residential location     
Urban     14(16.7%) 70(83.3%) 1.34(0.52 - 3.46) 2.4(0.30-19.6) 
Rural  8(15.6%) 43(84.4%) 1* 1* 
Educational status     
No formal education 6(21.4%) 22(78.6%) 0.67(0.21 - 2.15) 1.471(0.25-8.78) 
Primary or secondary 
education 
7(9.2%) 69(90.8%) 0.25(0.08 - 0.73)  0.53(0.11-2.52) 
Post-secondary education 9(29%) 22(71%) 1* 1* 
Marital status      
Married  20(15.6%) 108(84.4%) 0.47(0.09-2.27) 0.65(0.02-17.8) 
Single  2(28.6%) 5(71.4%) 1* 1* 
Gravidity      
1 10(16.7%) 50(82.3%) 1.19(0.35-4.0) 4.14(0.33-52.3) 
2-4 10(15.8%) 53(84.2%) 0.57(0.14-2.29) 1.7(0.18-16.2) 
≥ 5 2(16.6%) 10(83.4%) 1* 1* 
History of 
contraception 
    
Yes  16(18.2%) 72(81.8%) 1.52(0.52-4.15) 1.11(0.28-4.39) 
No  6(12.8%) 41(87.2%) 1* 1* 
History of PTD     
Yes     6(40%)    9(60%) 4.33(1.35-13.81) 6.35(1.42-28.35)† 
No     16(13.3%)   04(86.7%)       1* 1* 
History of PROM     
Yes     2(28.5%)    5(71.5%) 2.0(1.41-9.82) 3.32(0.41-26.9) 
No     20(15.6%) 108(84.4%) 1* 1* 
History of UTI during 
current pregnancy 
    
Yes   11(39.3%)   17(60.7%) 5.6(2.11-15.1) 6.4(1.95-21.1) † 
No    11(10.2%)   96(89.8%) 1* 1* 
N.B. 1* - reference, † statistically significant at P-Value < 0.05, COR- Crude Odds Ratio, AOR- Adjusted Odds 
Ratio 
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Our study examined the prevalence as well as 
predictors of colonization, and antibiotic 
susceptibility of GBS isolates among near term 
pregnant women in Southwest Ethiopia. Our 
study showed a 16.3% prevalence of GBS recto-
vaginal colonization. This finding is in the range 
of the USA prevalence reports of 15-40% (3) and 
other studies done in parts of Africa: Egypt: 
17.89% (15), Malawi: 16.5% (14), Nigeria: 
11.3% (13), Tanzania:  23% (16), and Democratic 
Republic of Congo (DRC): 20% (29). The result 
is also comparable to most of the studies done in 
Ethiopia with a prevalence range of 11.3% - 
20.9% (19-22). However, a lower prevalence of 
recto-vaginal colonization was reported in south 
India: 2.3% (30), Mozambique: 1.8% (31), and 
two Ethiopian studies done earlier with 7.2% in 
Addis Ababa (17) and 9% in Gondar (18). The 
variation in prevalence at different places could 
be due to differences in sample size and study 
period, as our study was a cross-sectional study 
during a shorter period. Additionally, there is 
variation in the GBS colonization rate when 
sampled from rectal and/or vaginal sites of the 
body, and identification of GBS from clinical 
specimens varies from one study to another. 
Identification of risk factors associated 
with GBS colonization has a paramount effect in 
reducing maternal and neonatal complications in 
resource-limited countries like Ethiopia, where 
routine screening is not the practice (32). In this 
study, risk factors associated with GBS 
colonization were history of preterm birth and 
UTI during the current pregnancy. History of 
both PTD and UTI during the current pregnancies 
were associated with six-fold higher odds of GBS 
colonization. Similar findings have been reported 
in a study done in the DRC (29). In women with 
history of PTD or UTI, it is several times as likely 
to have GBS colonization compared to those who 
don’t have either history. In this instance, GBS 
colonization is one of the agents associated with 







In our study, the majority of the isolates were 
susceptible to Ampicillin (95.5%) and Penicillin 
G (90.9%), which is different from most studies 
conducted previously in which all isolates were 
susceptible to these two drugs (16, 20-22,33). The 
United States of America Centers for Disease 
Control and prevention (CDC) recommends that 
penicillin remains the agent of choice for IAP, 
with Ampicillin as an acceptable alternative to 
prevent GBS colonization and infection (7). This 
study claims that, considering the observed low 
rates of GBS resistance to penicillins, it is 
mandatory to extend the study on the GBS 
colonization rate among near term pregnant 
women with a larger number of study participants 
over a longer period of time. Besides, since there 
is no treatment guideline in this study location, it 
would be logical to consider GBS culture and 
susceptibility testing routinely to select for 
effective antimicrobial agents. 
According to the USA CDC guidelines, 
penicillin-allergic women at high risk for 
anaphylaxis ought to receive Clindamycin if their 
GBS isolate is susceptible to Clindamycin and 
Erythromycin (7). In this study, half of the 
isolates were resistant to Erythromycin. This is 
consistent with reports from other studies done in 
Nigeria, 35.3% (13), and Palestine, 43% (33). 
The findings of this study also indicated that 
40.9% of the isolates were resistant to 
Clindamycin. Gentamicin, on the other hand, 
showed 100% resistance to GBS isolates in our 
study that has been used in combination with 
penicillin for severe GBS associated infections 
(34). These increased rates of GBS resistance to 
Erythromycin, Clindamycin, and Gentamicin 
highlight the importance of mandatory 
antimicrobial susceptibility testing in all GBS 
isolated from pregnant women. 
The strengths of this study are the more 
valid method used to identify GBS colonization, 
which is culture, and the prospective nature of 
data collection. However, this study is limited 
given the fact that it is a cross-sectional study to 
establish temporality between risk factors and 
GBS colonization. Moreover, since the 
participants were approached in a health facility, 
the findings may not be generalizable to the target 
population. 
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In conclusion, the prevalence of GBS recto-
vaginal colonization among near-term pregnant 
women is comparable to most of the studies done 
in Ethiopia and most parts of the world. In 
resource-limited areas, where universal screening 
is not feasible, selective screening for the 
identified predictors may be a reasonable option. 
Further study to identify risk factors for recto-
vaginal colonization at community level is 
recommended. Antibiotic susceptibility of the 
bacterium to Ampicillin and Penicillin G was 
high. The increased resistance rates to both 
Erythromycin and Clindamycin emphasize that 
antibiotic susceptibility tests should be done in 
women with allergy to penicillin. GBS is resistant 
to Gentamycin; reconsideration must occur 
before using this drug for GBS related infections 
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